Medicare Enrolled
Dr. Richard Hyman, MD
Cardiovascular Disease · Newtown, PA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hyman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hyman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hyman
Dr. Richard Hyman is a cardiovascular disease specialist in Newtown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hyman performed 4,658 Medicare services across 3,131 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hyman received a total of $4,789 from 31 pharmaceutical and/or device companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hyman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in PA
$4,789 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,658
Medicare services
Top 10% in PA for cardiovascular disease
3,131
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~233 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,315 | $11 | $152 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,314 | $94 | $413 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
365 | $65 | $300 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
252 | $150 | $385 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
240 | $41 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
151 | $97 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
136 | $50 | $700 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
134 | $7 | $72 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
122 | $106 | $492 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $142 | $800 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
89 | $139 | $550 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
85 | $44 | $488 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
84 | $358 | $2,400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $119 | $616 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
32 | $17 | $164 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
32 | $11 | $179 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
30 | $173 | $1,927 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
28 | $2 | $53 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
27 | $86 | $641 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
26 | $6 | $433 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
14 | $89 | $1,382 |
| New patient office visit, complex (60-74 min) | 11 | $175 | $759 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
14.9% medium
79.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,789
Total received (2018-2024)
Avg $684/year across 7 years
Top 35% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
227
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,789 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$450
2023
$663
2022
$801
2021
$169
2020
$762
2019
$759
2018
$1,185
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$111
Kiniksa Pharmaceuticals International, plc
$83
Edwards Lifesciences Corporation
$62
Boston Scientific Corporation
$53
Recor Medical Inc
$37
SCPHARMACEUTICALS INC.
$21
Lexicon Pharmaceuticals, Inc.
$18
AGEPHA Pharma FZ LLC
$18
AstraZeneca Pharmaceuticals LP
$17
Esperion Therapeutics, Inc.
$16
Amgen Inc.
$15
Top 3 companies account for 57.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,005
Amgen Inc.
$624
PFIZER INC.
$427
Novartis Pharmaceuticals Corporation
$363
E.R. Squibb & Sons, L.L.C.
$303
Janssen Pharmaceuticals, Inc
$274
Edwards Lifesciences Corporation
$268
BOSTON SCIENTIFIC CORPORATION
$178
SANOFI-AVENTIS U.S. LLC
$162
AstraZeneca Pharmaceuticals LP
$153
ABIOMED
$146
Abbott Laboratories
$119
Amarin Pharma Inc.
$96
Kiniksa Pharmaceuticals International, plc
$83
Merck Sharp & Dohme LLC
$79
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$74
Esperion Therapeutics, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$61
Philips Electronics North America Corporation
$41
Impulse Dynamics (USA) Inc.
$38
Recor Medical Inc
$37
Kestra Medical Technology Services, Inc.
$30
Cook Medical LLC
$24
SCPHARMACEUTICALS INC.
$21
Azurity Pharmaceuticals, Inc.
$18
Lexicon Pharmaceuticals, Inc.
$18
AGEPHA Pharma FZ LLC
$18
Kiniksa Pharmaceuticals, Ltd.
$17
ARALEZ PHARMACEUTICALS US INC.
$16
CVRx, Inc.
$14
Gilead Sciences, Inc.
$11
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
(1653) Diagnostic ECG Service · (5091) Amb Mon & Diag Und · AMPLATZER Occluders · Arcalyst · Assure WCD · BRILINTA · Barostim Neo System · CHANTIX · Cook Medical Thoracic · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · Impella · LEQVIO · LODOCO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MITRACLIP · MULTAQ · Mitra Clip system · NEXLETOL · OPTIMIZER · PARADISE RENAL DENERVATION SYSTEM · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · Prolia · Repatha · SAPIEN 3 Ultra RESILIA · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
491
Per 100K population
76.0
County median income
$111,951
Nearest hospital
ST MARY MEDICAL CENTER
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hyman is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 10% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hyman experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Hyman performed 1,315 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hyman receive payments from pharmaceutical companies?
Yes. Dr. Hyman received a total of $4,789 from 31 companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hyman's costs compare to other cardiologists in Newtown?
Dr. Hyman's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hyman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Newtown
Browse cardiologists in Newtown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology